Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease ProgressionShancheng Ren, Jun Pang, Fuqiang Li et al.|European Urology|2017Cited by 202
Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible ElectroporationHaifeng Wang, Chuanliang Xu, Wei Xue et al.|JAMA Surgery|2022Cited by 67
Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsyRui Chen, Yinghao Sun, Liping Xie et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 37
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/mlRui Chen, Yinghao Sun, Yong Huang et al.|PLoS ONE|2015Cited by 25
A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study ProtocolBiming He, Haifeng Wang, Wei Xue et al.|Frontiers in Oncology|2021Cited by 6